Cardiff Oncology Inc. sell goldmanns
Start price
18.03.24
/
0%
€4.51
Target price
18.03.25
-
Performance (%)
-48.23%
Price
02.10.24
€2.34
Summary
This prediction is currently active. The SELL prediction by goldmanns for Cardiff Oncology Inc. is performing very well with a performance of -48.23%. This prediction currently runs until 18.03.25. The prediction end date can be changed by goldmanns at any time. This prediction was marked as speculative and is excluded from goldmanns's performance statistics.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cardiff Oncology Inc. | -5.274% | -5.274% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by goldmanns for this prediction
In the thread Trovagene diskutieren
Sell Cardiff Oncology Inc.